Latest news
Axsome Q2 Revenue Rises 46 Percent To $218.4 Million - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:12:00 GMTHennion & Walsh Asset Management Inc. Sells 19,128 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Mon, 10 Aug 2026 09:45:19 GMTInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:41 GMTAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 4,660 Shares - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:40 GMTAXSOME THERAPEUTICS Q2 2026 Earnings Preview: Recent $AXSM Insider Trading, Hedge Fund Activity, and More - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 21:08:00 GMTAXSM (AXSM) holder files to sell 4,660 shares via cashless option exercise - Stock TitanStock Titan · Thu, 06 Aug 2026 21:10:07 GMTCalifornia State Teachers Retirement System Grows Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Thu, 06 Aug 2026 10:22:26 GMTAxsome Therapeutics (AXSM) insider plans 45,004-share cashless option sale - Stock TitanStock Titan · Wed, 05 Aug 2026 22:04:38 GMT